Cingulate Inc (CING)
4.575
-0.08
(-1.61%)
USD |
NASDAQ |
Nov 22, 13:41
Cingulate Shareholders Equity (Quarterly): 12.04M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 12.04M |
| June 30, 2024 | 3.084M |
| March 31, 2024 | 3.216M |
| December 31, 2023 | -6.869M |
| September 30, 2023 | -0.0963M |
| June 30, 2023 | -6.098M |
| March 31, 2023 | 0.0816M |
| December 31, 2022 | 3.882M |
| Date | Value |
|---|---|
| September 30, 2022 | 8.366M |
| June 30, 2022 | 12.18M |
| March 31, 2022 | 16.02M |
| December 31, 2021 | 20.84M |
| September 30, 2021 | 3.079M |
| June 30, 2021 | 1.899M |
| December 31, 2020 | 1.292M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-6.869M
Minimum
Dec 2023
20.84M
Maximum
Dec 2021
4.861M
Average
3.084M
Median
Jun 2024
Shareholders Equity (Quarterly) Benchmarks
| United Therapeutics Corp | 6.101B |
| Tonix Pharmaceuticals Holding Corp | 74.21M |
| Geovax Labs Inc | 8.504M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.58M |
| Total Liabilities (Quarterly) | 1.542M |